Literature DB >> 16483737

The transfer of a LC-UV method for the determination of fenofibrate and fenofibric acid in Lidoses: use of total error as decision criterion.

E Rozet1, B Mertens, W Dewe, A Ceccato, B Govaerts, B Boulanger, P Chiap, B Streel, J Crommen, Ph Hubert.   

Abstract

Two new statistical approaches to assess the validity of the transfer of a LC-UV method for the determination of fenofibrate and fenofibric acid were investigated and compared to the conventional approaches generally used in this domain. These new approaches, namely the Tolerance Interval and the Risk approaches, are based on the simultaneous evaluation of the systematic (or trueness) and random (or precision) errors of the transfer into a single criterion called total error (or accuracy). The results of the transfer showed that only the total error based approaches fulfilled the objective of an analytical method transfer, i.e. to give guarantees that each future measurement made by the receiving laboratory will be close enough to the true value of the analyte in the sample. Furthermore the Risk approach was the most powerful one and allowed the estimation of the risk to have future measurements out of specification in the receiving laboratory, therefore being a risk management tool.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16483737     DOI: 10.1016/j.jpba.2005.12.037

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Transfer of drug dissolution testing by statistical approaches: Case study.

Authors:  Mohammed Amood Al-Kamarany; Miloud El Karbane; Khadija Ridouan; Fars K Alanazi; Philippe Hubert; Yahia Cherrah; Abdelaziz Bouklouze
Journal:  Saudi Pharm J       Date:  2011-09-16       Impact factor: 4.330

2.  Development and validation of bioanalytical UHPLC-UV method for simultaneous analysis of unchanged fenofibrate and its metabolite fenofibric acid in rat plasma: Application to pharmacokinetics.

Authors:  Rayan G Alamri; Kazi Mohsin; Ajaz Ahmad; Mohammad Raish; Fars K Alanazi
Journal:  Saudi Pharm J       Date:  2016-05-26       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.